RTSN · Retension Pharmaceuticals, Inc. · Proposed Sales
Market Cap
$134.81M
Shares
8.33M
Volume · Oct 20
98.37K
Avg daily vol (8 sessions)
235.95K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.